Drugs stocks
The 811 US-listed companies classified as drugs (SIC group 283), largest first.
Prices as of Nov 17, 2026
Market value
$5.81T
811 companies
Year to date
−20.0%
On the day −1.06%
Over 52 weeks
−17.3%
Weighted by market value
P/E
69.7×
Net margin 9.6%
Drugs companies
The 200 largest of 798, ranked by market cap at the latest close. Revenue, margin and P/E use the last twelve months.
| # | Company | Market cap | Price | 1D | YTD | 1Y | Revenue | Net margin | P/E |
|---|---|---|---|---|---|---|---|---|---|
| 1 | $1.33T | $1,415.55 | −1.13% | +31.72% | +38.55% | $86.46B | 31.9% | 48.3× | |
| 2 | $670.92B | $278.70 | −1.36% | +34.67% | +39.64% | $99.34B | 16.2% | 41.7× | |
| 3 | $517.45B | $292.82 | −0.59% | +28.15% | +25.14% | $64.39B | 9.8% | 82.0× | |
| 4 | $356.41B | $144.46 | −2.23% | +37.24% | +55.47% | $66.57B | 4.8% | 112.3× | |
| 5 | $247.57B | $457.93 | −0.95% | +39.91% | +34.01% | $38.90B | 24.1% | 26.4× | |
| 6 | $211.18B | $170.26 | +1.60% | +38.72% | +37.21% | $30.99B | -12.5% | – | |
| 7 | $181.73B | $40.70 | −2.16% | −20.01% | −16.01% | – | – | – | |
| 8 | $181.19B | $104.71 | −2.55% | −16.43% | −19.47% | $46.59B | 11.6% | 33.4× | |
| 9 | $164.49B | $28.86 | −0.10% | +15.90% | +15.16% | $63.70B | 6.8% | 38.0× | |
| 10 | $135.40B | $534.20 | −0.67% | +17.83% | +23.08% | $12.59B | 35.0% | 30.7× | |
| 11 | $125.40B | $61.35 | −2.51% | +13.74% | +31.06% | $50.03B | 18.5% | 13.6× | |
| 12 | $115.92B | $47.53 | −1.78% | −1.92% | −8.21% | – | – | – | |
| 13 | $106.25B | $49.24 | −2.32% | +0.41% | +3.60% | – | – | – | |
| 14 | $99.08B | $957.76 | +0.56% | +24.08% | +35.99% | $16.90B | 28.5% | 20.6× | |
| 15 | $82.56B | $206.80 | −3.93% | +601.3% | +735.2% | $2.23B | -141.4% | – | |
| 16 | $74.58B | $21.64 | +0.23% | +38.81% | +53.04% | – | – | – | |
| 17 | $54.38B | $690.24 | −1.49% | +2.03% | +3.17% | $4.55B | 25.0% | 47.7× | |
| 18 | $49.61B | $42.57 | −4.34% | +36.40% | +67.53% | $14.10B | 5.0% | 70.3× | |
| 19 | $46.99B | $413.26 | +0.48% | +36.03% | +9.73% | $6.13B | 10.7% | 71.7× | |
| 20 | $39.49B | $68.68 | +0.23% | +77.74% | +75.38% | $2.54B | 32.1% | 48.5× | |
| 21 | $37.07B | $250.79 | −0.34% | +42.50% | +52.29% | $10.30B | 3.4% | 106.7× | |
| 22 | $34.87B | $162.69 | −2.50% | +104.3% | +135.3% | $0 | – | – | |
| 23 | $34.50B | $83.48 | −1.08% | −33.65% | −29.73% | $9.52B | 27.5% | 13.2× | |
| 24 | $27.96B | $38.71 | +0.26% | +78.39% | +88.28% | $7.53M | -3535.0% | – | |
| 25 | $26.73B | $121.86 | −0.83% | −29.98% | −38.27% | $1.52B | -39.9% | – | |
| 26 | $25.05B | $584.10 | −0.64% | +19.88% | +23.77% | $3.15B | 41.6% | 19.1× | |
| 27 | $23.49B | $20.45 | −1.40% | +64.26% | +91.84% | $14.74B | – | – | |
| 28 | $21.32B | $84.86 | −0.47% | −10.86% | −17.35% | – | – | – | |
| 29 | $20.96B | $156.50 | −2.02% | −60.64% | −66.02% | $5.01B | 52.8% | 7.9× | |
| 30 | $16.87B | $165.92 | +0.37% | +16.99% | +15.58% | $3.37B | 20.9% | 23.9× | |
| 31 | $16.81B | $271.19 | −0.20% | +27.18% | +25.23% | $1.16B | 70.8% | 20.5× | |
| 32 | $16.71B | $68.50 | +2.09% | +56.29% | +61.48% | $2.50B | 35.5% | 18.9× | |
| 33 | $15.63B | $240.71 | +0.39% | +41.59% | +41.52% | $4.72B | 4.4% | 75.9× | |
| 34 | $14.96B | $76.80 | −0.72% | +0.41% | +14.80% | $945.54M | – | – | |
| 35 | $14.95B | $95.11 | +0.93% | +130.6% | +129.7% | $945.96M | 11.6% | 136.4× | |
| 36 | $12.92B | $25.85 | −2.12% | +14.23% | +20.68% | $5.02B | -4.0% | – | |
| 37 | $12.34B | $14.79 | +0.61% | +5.34% | +5.95% | – | – | – | |
| 38 | $11.41B | $72.63 | −0.22% | +23.50% | +23.92% | $1.22B | 9.0% | 104.1× | |
| 39 | $11.33B | $58.51 | +0.90% | −1.55% | +7.44% | $3.41B | 2.1% | 155.2× | |
| 40 | $10.89B | $95.97 | −0.55% | +42.60% | +36.01% | $1.66B | 24.9% | 26.3× | |
| 41 | $10.79B | $49.75 | −0.12% | +5.10% | +7.10% | – | – | – | |
| 42 | $10.37B | $121.52 | −3.44% | +56.18% | +89.58% | $102.24M | -341.8% | – | |
| 43 | $10.37B | $162.18 | −0.37% | −1.03% | +8.85% | $805.61M | -1.5% | – | |
| 44 | $9.75B | $421.99 | −0.46% | −27.54% | −23.75% | $1.28B | -25.3% | – | |
| 45 | $9.60B | $62.71 | −0.08% | +110.4% | +104.3% | $799.54M | 55.2% | 21.7× | |
| 46 | $8.84B | $59.40 | −3.59% | +28.74% | +22.88% | – | – | – | |
| 47 | $8.84B | $298.55 | +0.22% | +21.10% | +43.36% | $440.48M | 54.8% | 36.6× | |
| 48 | $8.52B | $305.06 | −1.68% | +3.50% | +54.40% | $0 | – | – | |
| 49 | $8.51B | $10.67 | −9.73% | −38.99% | −37.05% | $0 | – | – | |
| 50 | syreSpyre Therapeutics | $8.27B | $93.81 | −5.60% | +186.4% | +285.1% | $0 | – | – |
| 51 | $8.07B | $124.67 | −0.13% | +42.74% | +47.07% | $281.99M | 29.4% | 97.3× | |
| 52 | $8.03B | $116.61 | +8.49% | +8.94% | +15.81% | $239.92M | -85.6% | – | |
| 53 | $7.62B | $45.45 | −2.32% | +62.44% | +54.96% | $1.67B | 4.0% | 115.3× | |
| 54 | $7.57B | $70.07 | +1.23% | +101.4% | −6.72% | $830.81M | 6.6% | 137.3× | |
| 55 | $7.18B | $51.65 | −2.86% | −18.71% | −22.85% | $67.67M | -1321.1% | – | |
| 56 | $7.12B | $135.95 | −0.77% | −25.56% | −6.60% | $776.57M | -24.7% | – | |
| 57 | $7.02B | $112.00 | +6.63% | +253.1% | +323.3% | $431.80M | -31.7% | – | |
| 58 | $7.00B | $78.94 | −6.89% | +90.13% | +91.37% | $6.17M | -3851.1% | – | |
| 59 | $6.86B | $33.21 | −0.21% | +30.65% | +36.67% | – | – | – | |
| 60 | $6.74B | $21.12 | −0.52% | +67.62% | +82.38% | $3.12B | 5.0% | 42.9× | |
| 61 | $6.64B | $101.80 | +0.08% | +52.97% | +93.90% | $1.56B | 17.7% | 24.1× | |
| 62 | $6.63B | $6.26 | +4.68% | +216.2% | +208.4% | $165.79M | -598.6% | – | |
| 63 | $6.45B | $82.10 | −1.81% | −39.12% | −27.74% | – | – | – | |
| 64 | $6.38B | $96.32 | −2.94% | +217.8% | +241.2% | – | – | – | |
| 65 | $6.20B | $157.72 | −2.98% | −1.40% | +34.91% | – | – | – | |
| 66 | $6.08B | $96.80 | −3.90% | +246.2% | +388.1% | – | – | – | |
| 67 | $6.07B | $42.99 | −2.76% | −35.25% | +7.07% | $669.50M | -47.8% | – | |
| 68 | $5.97B | $91.95 | +0.40% | +16.41% | +27.34% | $618.07M | -139.2% | – | |
| 69 | $5.88B | $293.81 | −2.62% | +55.40% | +45.92% | $253.83M | 20.3% | 114.2× | |
| 70 | $5.49B | $45.08 | +1.21% | +2.34% | +23.61% | $0 | – | – | |
| 71 | $5.40B | $11.04 | +0.55% | −95.55% | −95.38% | $53.29M | -235.0% | – | |
| 72 | $5.25B | $125.64 | −1.88% | – | – | – | – | – | |
| 73 | $5.08B | $56.73 | +0.64% | +64.48% | +99.75% | $450.91M | 30.7% | 36.6× | |
| 74 | $5.04B | $60.36 | −1.00% | −20.54% | −20.16% | $1.16B | -9.2% | – | |
| 75 | dnthDianthus Therapeutics | $4.87B | $86.98 | −2.87% | +111.1% | +110.4% | $2.04M | -9927.5% | – |
| 76 | $4.86B | $13.89 | −8.07% | +273.4% | +384.0% | – | – | – | |
| 77 | $4.83B | $27.85 | +1.49% | −21.59% | −17.48% | – | – | – | |
| 78 | $4.82B | $51.10 | +2.82% | +33.73% | +44.19% | $591.33M | -7.4% | – | |
| 79 | $4.57B | $42.04 | −3.75% | +69.41% | +88.86% | – | – | – | |
| 80 | $4.55B | $28.49 | +2.22% | +75.43% | +107.8% | $308.08M | -20.7% | – | |
| 81 | $4.48B | $26.96 | −3.75% | −65.92% | −63.20% | $874.09M | -64.7% | – | |
| 82 | $3.95B | $29.38 | −2.59% | +119.4% | +159.1% | – | – | – | |
| 83 | $3.88B | $40.15 | −0.54% | −23.44% | −27.42% | $13.39M | -3368.7% | – | |
| 84 | $3.87B | $19.15 | +156.4% | +408.0% | +1258% | – | – | – | |
| 85 | $3.76B | $38.78 | −1.22% | −13.48% | −4.51% | $0 | – | – | |
| 86 | $3.73B | $22.11 | −8.52% | +149.5% | +177.1% | $53.81M | -229.9% | – | |
| 87 | $3.65B | $23.53 | +0.26% | +33.39% | +12.48% | $449.61M | -41.9% | – | |
| 88 | $3.65B | $13.90 | 0.00% | +93.86% | +81.70% | $6.10B | 3.5% | 17.1× | |
| 89 | $3.61B | $16.47 | −4.63% | +94.68% | +148.8% | $10.35M | -2763.6% | – | |
| 90 | $3.49B | $28.25 | −0.70% | – | – | – | – | – | |
| 91 | $3.44B | $27.33 | +0.66% | −5.89% | +4.43% | $463.98M | 6.1% | 120.5× | |
| 92 | $3.43B | $46.85 | −1.62% | +204.2% | +115.3% | – | – | – | |
| 93 | $3.43B | $78.20 | −0.61% | −4.49% | +5.43% | $606.33M | -7.7% | – | |
| 94 | $3.43B | $26.88 | +0.30% | −23.59% | −29.67% | $0 | – | – | |
| 95 | $3.43B | $29.04 | +0.73% | −19.06% | −7.46% | $1.37B | 32.8% | 7.6× | |
| 96 | $3.41B | $7.53 | −0.26% | +175.8% | +211.2% | $324.97M | -89.1% | – | |
| 97 | $3.41B | $30.06 | +0.87% | −3.41% | +3.66% | $71.13M | -544.1% | – | |
| 98 | $3.38B | $11.03 | −0.81% | +222.5% | +206.4% | $66.17M | -248.8% | – | |
| 99 | bgmBGM | $3.26B | $8.13 | +1.50% | −92.66% | −97.02% | – | – | – |
| 100 | $3.17B | $8.47 | +0.59% | +21.87% | +38.17% | $11.11B | -7.6% | – | |
| 101 | $3.16B | $18.32 | −1.87% | −31.41% | −23.70% | $1.14B | 33.4% | 8.3× | |
| 102 | $3.07B | $27.52 | −1.01% | +127.8% | +96.85% | $0 | – | – | |
| 103 | $3.06B | $16.80 | +0.60% | +114.0% | +131.4% | $335.41M | -5.1% | – | |
| 104 | $3.05B | $13.63 | +1.19% | −25.27% | −11.61% | $512.28M | 33.0% | 18.1× | |
| 105 | $3.00B | $8.86 | −0.73% | +18.22% | −3.33% | – | – | – | |
| 106 | $2.99B | $16.02 | −4.07% | −18.10% | −20.85% | – | – | – | |
| 107 | $2.98B | $16.11 | +0.75% | −25.90% | −45.79% | $1.27B | -17.2% | – | |
| 108 | $2.97B | $8.63 | −1.15% | −7.70% | +1.53% | – | – | – | |
| 109 | $2.96B | $57.88 | +0.70% | +60.73% | +46.79% | $306.30M | 7.9% | 122.4× | |
| 110 | $2.94B | $76.57 | −0.03% | −3.58% | −14.59% | – | – | – | |
| 111 | $2.88B | $18.00 | −0.44% | +9.02% | +3.63% | $0 | – | – | |
| 112 | $2.64B | $27.40 | −9.75% | −20.74% | −17.82% | $234.13M | -74.8% | – | |
| 113 | $2.57B | $34.50 | −2.54% | +125.3% | +120.9% | $104.97M | -155.6% | – | |
| 114 | $2.56B | $53.10 | −0.04% | +68.36% | +107.3% | – | – | – | |
| 115 | $2.51B | $14.40 | −2.24% | +8.03% | −2.24% | – | – | – | |
| 116 | $2.38B | $10.90 | +0.18% | +55.94% | +69.78% | $883.99M | -6.3% | – | |
| 117 | $2.32B | $19.39 | −0.36% | −44.73% | −49.71% | $7.12M | -3644.2% | – | |
| 118 | $2.28B | $48.22 | +0.46% | −21.83% | −18.24% | $1.10B | 15.6% | 13.3× | |
| 119 | $2.27B | $34.39 | −1.15% | +5.17% | +11.80% | – | – | – | |
| 120 | $2.26B | $4.55 | −3.60% | −78.33% | −64.81% | – | – | – | |
| 121 | $2.20B | $28.04 | −1.92% | +3.24% | +7.85% | $158.00K | -190220.9% | – | |
| 122 | $2.19B | $15.76 | −2.60% | +13.22% | +16.22% | $4.14B | -41.9% | – | |
| 123 | $2.13B | $20.65 | −1.38% | −25.51% | −6.22% | $156.04M | -54.7% | – | |
| 124 | $2.10B | $32.28 | −0.49% | +16.32% | +29.53% | – | – | – | |
| 125 | $2.09B | $16.39 | −2.79% | −31.22% | −18.01% | $117.00M | -393.2% | – | |
| 126 | $2.08B | $144.35 | −0.17% | +37.91% | +76.81% | – | – | – | |
| 127 | $2.06B | $15.40 | −0.52% | −3.45% | −0.58% | $321.74M | 97.7% | 6.6× | |
| 128 | $2.00B | $13.24 | −4.06% | +17.27% | +60.10% | – | – | – | |
| 129 | $1.95B | $17.18 | −2.44% | −20.02% | −5.24% | $4.02M | -5593.8% | – | |
| 130 | $1.94B | $10.07 | −2.52% | +15.88% | +93.65% | $1.14B | – | – | |
| 131 | $1.92B | $13.51 | +1.66% | +7.91% | +19.03% | – | – | – | |
| 132 | $1.92B | $33.01 | +0.15% | −11.79% | −2.88% | $959.90M | 18.9% | 10.6× | |
| 133 | $1.92B | $25.66 | −6.21% | +43.51% | +46.96% | $259.04M | -21.0% | – | |
| 134 | $1.92B | $7.50 | +0.67% | −3.85% | +6.69% | $940.61M | -40.9% | – | |
| 135 | $1.89B | $7.28 | −1.62% | +124.0% | +118.0% | $208.78M | -37.1% | – | |
| 136 | $1.89B | $26.20 | −2.86% | −48.26% | −11.07% | – | – | – | |
| 137 | $1.87B | $40.02 | −3.96% | +43.54% | +84.94% | $96.27M | -61.3% | – | |
| 138 | $1.87B | $19.69 | −8.03% | +102.6% | +124.5% | – | – | – | |
| 139 | $1.83B | $25.84 | −2.31% | −1.86% | +8.12% | $37.13M | -404.0% | – | |
| 140 | $1.83B | $32.87 | −3.04% | −20.66% | −1.97% | $167.50M | -79.8% | – | |
| 141 | $1.82B | $39.06 | +0.01% | – | – | – | – | – | |
| 142 | $1.82B | $63.65 | −0.36% | +276.4% | +268.8% | $105.60M | 12.0% | 143.4× | |
| 143 | $1.81B | $27.75 | −0.64% | −23.57% | −22.66% | $10.00M | -5418.1% | – | |
| 144 | $1.78B | $29.89 | −0.86% | +9.81% | −33.77% | $98.34M | -418.2% | – | |
| 145 | $1.70B | $26.41 | −0.83% | −16.79% | −2.00% | $27.59M | -753.6% | – | |
| 146 | $1.69B | $18.78 | −3.64% | – | – | – | – | – | |
| 147 | $1.65B | $16.70 | +5.03% | −27.39% | −48.68% | $717.21M | -81.7% | – | |
| 148 | $1.61B | $69.99 | −1.27% | −11.34% | −14.62% | $978.38M | 11.1% | 14.8× | |
| 149 | $1.58B | $12.20 | −2.94% | – | – | – | – | – | |
| 150 | $1.57B | $9.25 | −3.44% | +53.40% | +68.49% | $303.23M | -83.0% | – | |
| 151 | $1.56B | $14.77 | −2.38% | −31.37% | −15.79% | $1.97B | -6.9% | – | |
| 152 | $1.56B | $43.57 | −6.42% | – | – | – | – | – | |
| 153 | $1.56B | $14.24 | −3.33% | −24.93% | +11.34% | $701.94M | 42.0% | 5.3× | |
| 154 | $1.54B | $11.91 | −4.34% | −33.98% | −21.07% | – | – | – | |
| 155 | $1.54B | $4.29 | −0.23% | +2.63% | −12.45% | – | – | – | |
| 156 | $1.48B | $13.82 | −1.29% | – | – | – | – | – | |
| 157 | $1.47B | $49.24 | +5.64% | +52.35% | +113.3% | $237.61M | 82.4% | 7.5× | |
| 158 | $1.46B | $29.87 | +6.30% | +27.54% | +26.03% | $188.73M | -51.7% | – | |
| 159 | $1.46B | $2.72 | −6.37% | −33.50% | −33.98% | $54.86M | -945.9% | – | |
| 160 | $1.45B | $36.48 | 0.00% | +40.96% | +52.76% | $746.16M | 2.0% | 99.3× | |
| 161 | $1.44B | $20.78 | −5.03% | −13.16% | −31.49% | $18.67M | -1350.7% | – | |
| 162 | $1.43B | $27.81 | −3.70% | −19.88% | −23.95% | $430.78M | -4.2% | – | |
| 163 | $1.42B | $34.92 | −0.29% | −6.53% | −22.50% | $1.52B | 6.6% | 14.2× | |
| 164 | $1.39B | $22.56 | +0.29% | −1.96% | −1.27% | – | – | – | |
| 165 | $1.37B | $9.78 | −0.81% | +8.79% | +15.33% | $59.51M | -672.2% | – | |
| 166 | $1.37B | $3.90 | +1.56% | −56.47% | −16.49% | $169.90M | -88.2% | – | |
| 167 | $1.36B | $4.37 | −0.79% | −14.81% | −14.98% | – | – | – | |
| 168 | $1.33B | $27.45 | −3.82% | +18.73% | +25.40% | – | – | – | |
| 169 | $1.32B | $18.30 | −1.03% | −8.45% | −16.70% | $438.32M | – | – | |
| 170 | $1.32B | $6.02 | +0.17% | −50.41% | −49.37% | $52.05M | -579.1% | – | |
| 171 | nvaxNovavax | $1.31B | $7.96 | −1.24% | +18.45% | +17.06% | $413.80M | -59.9% | – |
| 172 | $1.31B | $4.07 | +2.91% | −28.22% | −18.27% | $393.63M | -11.1% | – | |
| 173 | $1.30B | $4.00 | −1.48% | −27.27% | −2.91% | $5.49M | -2728.0% | – | |
| 174 | $1.30B | $40.30 | −6.26% | +81.04% | +136.4% | – | – | – | |
| 175 | $1.30B | $18.17 | −2.15% | −73.87% | −51.47% | – | – | – | |
| 176 | $1.28B | $14.48 | −0.34% | −60.10% | −67.28% | – | – | – | |
| 177 | genbGenerate Biomedicines | $1.26B | $9.84 | −6.20% | – | – | – | – | – |
| 178 | amphAmphastar Pharmaceuticals | $1.24B | $29.10 | −0.24% | +8.66% | +11.84% | $730.02M | 10.8% | 15.8× |
| 179 | $1.24B | $27.92 | −6.18% | +279100% | +279100% | – | – | – | |
| 180 | $1.23B | $13.19 | +2.65% | – | – | – | – | – | |
| 181 | $1.23B | $13.14 | −1.13% | −49.92% | −59.83% | – | – | – | |
| 182 | $1.23B | $35.91 | −1.45% | −15.07% | −39.73% | $55.23M | -297.1% | – | |
| 183 | $1.21B | $1.62 | 0.00% | +28.57% | +27.56% | $587.90M | -12.4% | – | |
| 184 | $1.18B | $3.19 | −2.45% | +21.29% | +31.82% | $179.09M | 39.1% | 16.8× | |
| 185 | $1.17B | $19.57 | −0.86% | −25.56% | +23.08% | – | – | – | |
| 186 | $1.14B | $23.76 | −4.27% | −21.69% | −5.38% | – | – | – | |
| 187 | $1.13B | $18.27 | −2.56% | +43.86% | +29.57% | – | – | – | |
| 188 | $1.12B | $18.18 | −4.16% | +38.99% | +81.44% | – | – | 0.8× | |
| 189 | $1.11B | $29.52 | +1.48% | −39.76% | −26.73% | $275.59M | -13.5% | – | |
| 190 | $1.11B | $7.98 | −3.51% | +15.65% | +49.72% | – | – | – | |
| 191 | $1.09B | $74.18 | −4.48% | −6.10% | −4.10% | $1.30M | -10896.8% | – | |
| 192 | $1.01B | $13.92 | −16.55% | −18.95% | +53.30% | – | – | 8.1× | |
| 193 | $999.81M | $19.74 | −0.30% | +105.6% | +132.0% | $186.45M | -20.1% | – | |
| 194 | $979.40M | $15.40 | +0.42% | −0.19% | +22.32% | – | – | – | |
| 195 | $977.52M | $24.91 | −8.15% | +39.94% | +80.51% | – | – | – | |
| 196 | sptxSeaport Therapeutics | $972.65M | $18.17 | −4.97% | – | – | – | – | – |
| 197 | $957.45M | $11.25 | −4.09% | −14.64% | −13.39% | – | – | – | |
| 198 | $935.48M | $19.80 | 0.00% | +225.7% | +195.5% | $456.00K | -11276.5% | – | |
| 199 | $930.89M | $19.37 | +0.05% | – | – | – | – | – | |
| 200 | $920.46M | $4.48 | +0.34% | −25.70% | +6.67% | – | – | – |
Compare companies in the screener or browse all industries.